In the context of APR and PQR, what is the significance of reviewing product complaints? Response:

Question

Options

• ATo adjust the product price
• BTo assess the product's packaging design
• CTo evaluate and improve product quality and safety
• DTo measure consumer brand loyalty

• A
  11% (3)
• B
  14% (4)
• C
  71% (20)
• D
  4% (1)

Explanation

APR (Annual Product Review) and PQR (Product Quality Review) are regulatory quality management processes in pharmaceutical manufacturing that require systematic analysis of all data related to a product - including complaints - to verify ongoing process consistency and identify improvement opportunities.

Reviewing product complaints is central to these processes because complaints are direct signals of potential quality or safety failures reaching patients. Analyzing complaint trends helps manufacturers detect manufacturing defects, identify root causes, implement corrective and preventive actions (CAPAs), and demonstrate regulatory compliance - all core objectives of APR/PQR under frameworks like ICH Q10 and FDA 21 CFR 211.180(e).

Why the distractors are wrong:

• A (price adjustment) - Pricing is a commercial/business function entirely outside the scope of quality review processes.
• B (packaging design) - Packaging aesthetics are a marketing concern; APR/PQR may flag functional packaging defects, but "assessing design" is not the purpose.
• D (brand loyalty) - Consumer loyalty is a marketing metric, not a quality or safety metric tracked in regulatory reviews.

Memory tip: Think of APR/PQR as a "health check" for your product. Just as a doctor reviews patient complaints to diagnose and treat problems, APR/PQR reviews product complaints to diagnose quality issues and improve safety - making C the only medically (and regulatorily) logical answer.

No community discussion yet for this question.